Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): A clinicopathologic study

American Journal of Surgical Pathology

Volumn 31, Issue 3, 2007, Pages 351-362

  Rodriguez, Fausto J ^a   Scheithauer, Bernd W ^a   Jenkins, Robert ^a   Burger, Peter C ^b   Rudzinskiy, Peter ^c   Vlodavsky, Euvgeni ^d   Schooley, Adam ^a   Landolfi, Joseph ^c  

^a MAYO CLINIC   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c NEW JERSEY NEUROSCIENCE INSTITUTE   (United States)

^d RAMBAM MEDICAL CENTER   (Israel)

Author keywords

1p 19q; FISH; Gliosarcoma; Metaplasia; Oligodendroglioma; Sarcoma

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; LOMUSTINE; PROCARBAZINE; PROTEIN S 100; TEMOZOLOMIDE; VINCRISTINE; TUMOR MARKER;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME DELETION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FIBROSARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; GLIOSARCOMA; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; OLIGOSARCOMA; SARCOMA; BRAIN; BRAIN TUMOR; CANCER STAGING; CASE REPORT; CHEMISTRY; CHROMOSOME 1; CHROMOSOME 19; FATALITY; GENETICS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SECOND CANCER; TUMOR RECURRENCE;

ADULT; AGED; BRAIN; BRAIN NEOPLASMS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; COMBINED MODALITY THERAPY; FATAL OUTCOME; FEMALE; GLIOSARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; OLIGODENDROGLIOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 34247599048     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000213378.94547.ae     Document Type: Article

References (29)

1. Agozzino L, Pittore L, Lamendola MG, et al. Sarcoma arising in a cerebral oligodendroglioma. Case report. Pathologica. 1983;75:501-508.
2. Barnard RO, Bradford R, Scott T, et al. Gliomyosarcoma. Report of a case of rhabdomyosarcoma arising in a malignant glioma. Acta Neuropathol (Berl). 1986;69:23-27.
3. Behling E, Birbe R, Veznadaroglu E, et al. Gliosarcoma arising from an anaplastic ependymoma: a case report of a rare entity. Hum Pathol. 2004;35:512-516.
4. Biernat W, Aguzzi A, Sure U, et al. Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells. J Neuropathol Exp Neurol. 1995;54:651-656.
5. Boerman RH, Anderl K, Herath J, et al. The glial and mesenchymal elements of gliosarcomas share similar genetic alterations. J Neuropathol Exp Neurol. 1996;55:973-981.
6. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst. 1998;90:1473-1479.
7. Carstens PH, Johnson GS, Jelsma LF. Spinal gliosarcoma: a light, immunohistochemical and ultrastructural study. Ann Clin Lab Sci. 1995;25:241-246.
8. Feigin I, Allen LB, Lipkin L, et al. The endothelial hyperplasia of the cerebral blood vessels with brain tumors, and its sarcomatous transformation. Cancer. 1958;11:264-277.
9. Feigin I, Ransohoff J, Lieberman A. Sarcoma arising in oligodendroglioma of the brain. J Neuropathol Exp Neurol. 1976;35:679-684.
10. Feigin IH, Gross SW. Sarcoma arising in glioblastoma of the brain. Am J Pathol. 1955;31:633-653.
11. Fletcher CD, Gustafson P, Rydholm A, et al. Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol. 2001;19:3045-3050.
12. Folpe AL, Allen M. Immunohistochemistry for analysis of soft tissue tumors. In: Weiss SW, Goldblum JR, eds. Enzinger and Weiss's Soft Tissue Tumors. St Louis: Mosby; 2001:222.
13. Haddad SF, Moore SA, Schelper RL, et al. Smooth muscle can comprise the sarcomatous component of gliosarcomas. J Neuropathol Exp Neurol. 1992;51:493-498.
14. Hayashi K, Ohara N, Jeon HJ, et al. Gliosarcoma with features of chondroblastic osteosarcoma. Cancer. 1993;72:850-855.
15. Horiguchi H, Hirose T, Kannuki S, et al. Gliosarcoma: an immunohistochemical, ultrastructural and fluorescence in situ hybridization study. Pathol Int. 1998;48:595-602.
16. Jenkins RB, Curran W, Scott CB, et al. Pilot evaluation of 1p and 19q deletions in anaplastic oligodendrogliomas collected by a national cooperative cancer treatment group. Am J Clin Oncol. 2001;24:506-508.
17. Jeuken JW, von Deimling A, Wesseling P. Molecular pathogenesis of oligodendroglial tumors. J Neurooncol. 2004;70:161-181.
18. Kepes JJ, Bastian FO, Weber ED. Gliosarcoma developing from an irradiated ependymoma. Acta Neuropathol (Berl). 1996;92:515-519.
19. Ohgaki H, Biernat W, Reis R, et al. Gliosarcoma. In: Kleihues P, Cavenee WK, eds. Pathology and Genetics of Tumours of the Nervous System World Health Organization Classification of Tumours. Lyon, France: IARC Press; 2000.
20. Ozolek JA, Finkelstein SD, Couce ME. Gliosarcoma with epithelial differentiation: immunohistochemical and molecular characterization. A case report and review of the literature. Mod Pathol. 2004;17:739-745.
21. Pasquier B, Couderc P, Pasquier D, et al. Sarcoma arising in oligodendroglioma of the brain: a case with intramedullary and subarachnoid spinal metastases. Cancer. 1978;42:2753-2758.
22. Paulus W, Bayas A, Ott G, et al. Interphase cytogenetics of glioblastoma and gliosarcoma. Acta Neuropathol (Berl). 1994;88:420-425.
23. Perry A, Fuller CE, Banerjee R, et al. Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics. Front Biosci. 2003;8:a1-a9.
24. Rubinstein L. Tumors of the Central Nervous System. 2nd ed. Washington, DC: AFIP; 1972:97-98.
25. Schiffer D, Giordana MT, Mauro A, et al. GFAP, F VIII/RAg, laminin, and fibronectin in gliosarcomas: an immunohistochemical study. Acta Neuropathol (Berl). 1984;63:108-116.
26. Schweitzer T, Vince GH, Herbold C, et al. Extraneural metastases of primary brain tumors. J Neurooncol. 2001;53:107-114.
27. Sreenan JJ, Prayson RA. Gliosarcoma. A study of 13 tumors, including p53 and CD34 immunohistochemistry. Arch Pathol Lab Med. 1997;121:129-133.
28. Stroebe H. Ueber entstehung und Bau der hirngliome. Bietr Pathol Anat Allg Pathol. 1895;18:405-486.
29. Winkler PA, Buttner A, Tomezzoli A, et al. Histologically repeatedly confirmed gliosarcoma with long survival: review of the literature and report of a case. Acta Neurochir (Wien). 2000;142:91-95.